183 related articles for article (PubMed ID: 24048791)
1. The role of technetium-99m methoxyisobutyl isonitrile scintigraphy in predicting the therapeutic effect of chemotherapy against nasopharyngeal carcinoma.
Wang XS; Zhang YJ; Liu XL; Zhou ZR; Hu CS; Eisbruch A
Cancer; 2011 Jun; 117(11):2435-41. PubMed ID: 24048791
[TBL] [Abstract][Full Text] [Related]
2. Prediction of the response to docetaxel-based chemotherapy for locoregionally advanced nasopharyngeal carcinoma: the role of double-phase (99m)Tc-MIBI SPECT/CT.
Du C; Ying H; Zhou J; Jiang J; Liu C; Chen J; Wang X; Hu C
Med Oncol; 2014 Feb; 31(2):833. PubMed ID: 24402323
[TBL] [Abstract][Full Text] [Related]
3. The role of Tc-99m sestamibi imaging in predicting clinical response to chemotherapy in lung cancer.
Dirlik A; Burak Z; Goksel T; Erinc R; Karakus H; Ozcan Z; Veral A; Ozhan M
Ann Nucl Med; 2002 Apr; 16(2):103-8. PubMed ID: 12043903
[TBL] [Abstract][Full Text] [Related]
4. [Examination of resistance of lung adenocarcinoma cells to cisplatin by technetium-99m methoxyisobutyl isonitrile].
Hu S; Hu CP; Liang CH
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1493-8. PubMed ID: 16061030
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of chest single photon emission computed tomography with technetium-99m methoxyisobutylisonitrile to predict taxol based chemotherapy response in advanced non-small cell lung cancer.
Shih CM; Hsu WH; Huang WT; Wang JJ; Ho ST; Kao A
Cancer Lett; 2003 Sep; 199(1):99-105. PubMed ID: 12963129
[TBL] [Abstract][Full Text] [Related]
6. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
Sergieva SB; Timcheva KV; Hadjiolov ND
J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m methoxyisobutylisonitrile chest imaging for small-cell lung cancer. Relationship to chemotherapy response (six courses of combination of cisplatin and etoposide) and p-glycoprotein or multidrug resistance related protein expression.
Kao A; Shiun SC; Hsu NY; Sun SS; Lee CC; Lin CC
Ann Oncol; 2001 Nov; 12(11):1561-6. PubMed ID: 11822755
[TBL] [Abstract][Full Text] [Related]
8. Imaging of nasopharyngeal carcinoma with Tc-99m MIBI.
Pui MH; Du JQ; Yueh TC; Zeng SQ
Clin Nucl Med; 1998 Jan; 23(1):29-32. PubMed ID: 9442962
[TBL] [Abstract][Full Text] [Related]
9. Tc-99m MIBI liver imaging for hepatocellular carcinoma: correlation with P-glycoprotein-multidrug-resistance gene expression.
Chang CS; Yang SS; Yeh HZ; Kao CH; Chen GH
Hepatogastroenterology; 2004; 51(55):211-4. PubMed ID: 15011866
[TBL] [Abstract][Full Text] [Related]
10. 99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis.
Yüksel M; Cermik TF; Doğanay L; Karlikaya C; Cakir E; Salan A; Berkarda S
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):876-81. PubMed ID: 12111127
[TBL] [Abstract][Full Text] [Related]
11. [Tentative results of using 99mTC-methoxyisobutyl isonitrile in predicting the effect of preoperative chemotherapy for locally advanced breast cancer].
Portnoĭ SM; Odzharova AA; Shiriaev SV; Anurova OA; Laktionov KP; Riabchikov DA
Vopr Onkol; 2006; 52(6):620-3. PubMed ID: 17338237
[TBL] [Abstract][Full Text] [Related]
12. Use of 99mTc-MIBI scintigraphy in the evaluation of the response to chemotherapy for osteosarcoma: comparison with 201Tl scintigraphy and angiography.
Miwa S; Shirai T; Taki J; Sumiya H; Nishida H; Hayashi K; Takeuchi A; Ooi A; Tsuchiya H
Int J Clin Oncol; 2011 Aug; 16(4):373-8. PubMed ID: 21331769
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of 99mTc-sestamibi scintigraphy in suggesting the therapeutic effect of chemotherapy against gastric cancer.
Kawata K; Kanai M; Sasada T; Iwata S; Yamamoto N; Takabayashi A
Clin Cancer Res; 2004 Jun; 10(11):3788-93. PubMed ID: 15173086
[TBL] [Abstract][Full Text] [Related]
14. Comparison of TI-201 and Tc-99m MIBI SPECT imaging in nasopharyngeal carcinoma.
Wang SJ; Hsu CY; Lin WY; Kao CH; Jan JS; Yeh SH
Clin Nucl Med; 1995 Sep; 20(9):800-2. PubMed ID: 8521656
[TBL] [Abstract][Full Text] [Related]
15. Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer.
Akgun A; Cok G; Karapolat I; Goksel T; Burak Z
Ann Nucl Med; 2006 May; 20(4):269-75. PubMed ID: 16856570
[TBL] [Abstract][Full Text] [Related]
16. Using technetium-99m methoxyisobutylisonitrile lung single-photon-emission computed tomography to predict response to chemotherapy and compare with P-glycoprotein expression in patients with untreated small cell lung cancer.
Changlai SP; Tsai CS; Ding HJ; Huang WT; Kao A; Hsu WH
Med Oncol; 2003; 20(3):247-53. PubMed ID: 14514974
[TBL] [Abstract][Full Text] [Related]
17. Quickly predicting chemotherapy response to paclitaxel-based therapy in non-small cell lung cancer by early technetium-99m methoxyisobutylisonitrile chest single-photon-emission computed tomography.
Kao CH; Hsieh JF; Tsai SC; Ho YJ; Lee JK
Clin Cancer Res; 2000 Mar; 6(3):820-4. PubMed ID: 10741702
[TBL] [Abstract][Full Text] [Related]
18. [Correlation of the uptake of technetium-99m methoxyisobutyl isonitrile with expression of multidrug resistance genes mdr-1 and MRP in human lung cancer].
Shi D; Huang G; Miao J; Lin X
Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(12):824-7. PubMed ID: 12126530
[TBL] [Abstract][Full Text] [Related]
19. Utility of technetium-99m methoxyisobutyl isonitrile uptake analysis for prediction of the response to chemotherapy in advanced and relapsed breast cancer.
Kim R; Osaki A; Hirai T; Toge T
Breast Cancer; 2002; 9(3):240-7. PubMed ID: 12185336
[TBL] [Abstract][Full Text] [Related]
20. Predicting chemotherapy response to paclitaxel-based therapy in advanced non-small-cell lung cancer (stage IIIb or IV) with a higher T stage (> T2). Technetium-99m methoxyisobutylisonitrile chest single photon emission computed tomography and P-glycoprotein express ion.
Hsu WH; Yen RF; Kao CH; Shiun SC; Hsu NY; Lin CC; Lee CC
Oncology; 2002; 63(2):173-9. PubMed ID: 12239453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
